February 06, 2019
Rose
Health Care, THCB
No comments
Related Posts:
India’s Health Insurance Experiment. Who will be the winners?By SAURABH JHA Though the exact cost of Modicare, the government’s extension of health insurance for poor people, estimated at one lakh crore (a trillion U.S. dollars), is open for debate, what is not disputable is that the c… Read More
The EBM Wars: When Evidence has a Price – The ECMO Trials (Part 2)By ANISH KOKA The year was 1965, the place was Boston Children’s and a surgery resident named Robert Bartlett took his turn at the bedside of a just born baby unable to breathe. This particular baby couldn’t brea… Read More
Adjusting for Risk Adjustment By JONATHAN HALVORSON Risk adjustment in health insurance is at first glance, and second, among the driest and most arcane of subjects. And yet, like the fine print on a variable-rate mortgage, it can matter enormously. It m… Read More
Defining Engagement in an Age of Patient Monitoring and Data CollectionSPONSORED POST By GRACE MOEN If you have an innovative solution that addresses Patient Engagement and Remote Monitoring, Bayer’s Dealmaker Challenge wants to hear from you! Apply here for a shot at collaborating with the Baye… Read More
Health in 2 Point 00, Episode 33, (another!) Takeover EditionJessica DaMassa hosts this edition of Health in 2 Point 00 on the Italian leg of her Grand Tour of Europe. This time it’s another takeover with Roberto Ascione, CEO of Healthware dishing on innovation on the Almafi Coast, the… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment